Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × belinostat × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 6 Lymphoma, T-Cell, Peripheral 6 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myeloid, Acute 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, T-Cell 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lung Neoplasms 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Recurrence 3 Neoplasms 3 Myelodysplastic Syndromes 3 Mycosis Fungoides 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Immunoblastic Lymphadenopathy 3 Fallopian Tube Neoplasms 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Thyroid Neoplasms 2

Interventions

pembrolizumab 76 Gemcitabine 48 Nivolumab 41 Cisplatin 35 atezolizumab 34 Carboplatin 27 avelumab 25 enfortumab vedotin 23 Docetaxel 22 Magnetic Resonance Spectroscopy 17 Paclitaxel 15 Ipilimumab 15 Mitomycin 14 Specimen Handling 12 durvalumab 10 toripalimab 9 sacituzumab govitecan 9 Pemetrexed 8 vinflunine 7 cabozantinib 7 Taxes 7 Injections 6 Cyclophosphamide 6 Bevacizumab 6 tislelizumab 5 pemigatinib 5 Standard of Care 5 Fluorodeoxyglucose F18 5 Biopsy 5 lenvatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05154994 2026-01-27

RESOLVE

University of Utah

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡